Sensus Healthcare, Inc.
Sensus Healthcare, Inc. (Nasdaq Capital Market: SRTS) operates as a medical device company focused on providing non-invasive treatments for non-melanoma skin cancer and post-surgical keloid scar prevention. The company's website is located at www.sensushealthcare.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Sensus Healthcare, Inc. does
In the company’s own words
Sensus Healthcare, Inc. (Nasdaq Capital Market: SRTS) operates as a medical device company focused on providing non-invasive treatments for non-melanoma skin cancer and post-surgical keloid scar prevention. The company's website is located at www.sensushealthcare.com.
The company's core technology is superficial radiation therapy, or SRT, a proprietary low-energy X-ray technology developed over decades of research. Sensus has successfully incorporated SRT into a portfolio of treatment devices including the SRT-100, SRT-100+, and SRT-100 Vision systems. To date, SRT technology has been used to treat approximately one million patients worldwide across 21 countries, with the majority of installations in the United States.
As of December 31, 2025, Sensus had installed 955 SRT units globally. The company operates as a single reportable segment from its corporate headquarters in Boca Raton, Florida, and employed 60 people at year-end 2025. The company formed a wholly owned subsidiary, Sensus Healthcare Services, LLC, in February 2024 to provide operational healthcare offerings to dermatology clinics through its Fair Deal Agreement service model, which offers revenue-sharing arrangements for equipment access and operation.
Sensus targets two primary markets: private dermatology practices and radiation oncologists in both private and hospital settings. The company employs a multi-tier sales strategy utilizing a direct sales force in the United States alongside international dealers and distributors. Substantially all revenue is generated from SRT product sales and related services, with 92 percent of revenues derived from U.S. customers in 2025. A single U.S. customer accounted for 52 percent of revenues in 2025.
The company manufactures products through third-party relationships, primarily with RbM Services, LLC, which has supplied SRT-100 products since 2010. Sensus also began contracting with Koplak, LLC in 2025 for special projects. The company possesses eight issued U.S. and global patents related to its SRT technology, with additional trademark registrations protecting its brand. In February 2026, the company launched Sensus Healthcare Financial Services to support product acquisition through flexible financing options and Sensus Link, a cloud-based software solution for enhanced operating capabilities across its installed base.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- BOCA RATON, FL
- Fiscal year end
- December
- CIK
- 1494891
- SIC
- 3841
Financial performance, year by year
Fiscal 2016–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Sensus Healthcare, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Sensus Healthcare, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Sensus Healthcare, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Sensus Healthcare, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Sensus Healthcare, Inc.'s last four quarterly filings that the numbers alone won't show?”